HMGB1 and pancreatic neoplasm: RAGE is needed for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer, according to Kang et al. In another study, they also revealed that by regulating mitochondrial bioenergetics, the HMGB1/RAGE inflammatory pathway promotes pancreatic tumor development.